Presence of Anti-drug Antibodies Does Not Reduce the Efficacy of an Oral Anti-TNF Antibody in a Murine IBD Model

被引：0
|
作者：
Bhol, Kailash [1 ]
Erlich, Emma [1 ]
Lemos, Brenda [1 ]
Tracey, Daniel [1 ]
Hartman, Deborah [1 ]
Fox, Barbara [1 ]
机构：
[1] Avaxia Biol Inc, Lexington, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01810
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1810
引用
收藏
页码：S545 / S546
页数：2
相关论文
共 50 条
  • [41] INCREASED FREQUENCY OF ANTI-DRUG ANTIBODIES IN PATIENTS CARRYING COMPATIBLE IGG1 ALLOTYPES AND TREATED WITH ANTI-TNF ANTIBODIES
    Lopez-Rodriguez, R.
    Martinez, A.
    Plasencia, C.
    Jochems, A.
    Pascual-Salcedo, D.
    Balsa, A.
    Gonzalez, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 59 - 59
  • [42] Increased Frequency of Anti-Drug Antibodies in Patients Carrying Compatible IgG1 Allotypes and Treated with Anti-TNF Antibodies
    Gonzalez, Antonio
    Lopez-Rodriguez, Rosario
    Martinez, Ana
    Plasencia-Rodriguez, Chamaida
    Jochems, Andrea
    Pascual-Salcedo, Dora
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
    Allez, M.
    Vermeire, S.
    Mozziconacci, N.
    Michetti, P.
    Laharie, D.
    Louis, E.
    Bigard, M. -A.
    Hebuterne, X.
    Treton, X.
    Kohn, A.
    Marteau, P.
    Cortot, A.
    Nichita, C.
    van Assche, G.
    Rutgeerts, P.
    Lemann, M.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 31 (01) : 92 - 101
  • [44] Development of an anti-drug antibody assay to detect anti-drug antibodies to protein and PEG in a PEGylated molecule
    Liu, Yanqiu
    Yu, Nancy
    Khosraviani, Mehraban
    Wakshull, Eric
    BIOANALYSIS, 2020, 12 (23) : 1671 - 1679
  • [45] Stability of Anti-Drug Antibodies Against Antibody Therapeutics
    Sirohi, Parul
    Hainline, Kelly
    Bullock, Heather
    Wang, Sihe
    Konrad, Robert J.
    Wen, Yi
    AAPS JOURNAL, 2025, 27 (01):
  • [46] ANTI-DRUG ANTIBODIES TO ANTI-TNFS: EXPERIENCE AND OUTCOMES AT A TERTIARY IBD CENTRE
    Sebepos-Rogers, Gregory
    Jayasooriya, Nishani
    Gadhok, Radha
    Gordon, Hannah
    O'Donnell, Sarah
    GUT, 2018, 67 : A92 - A93
  • [47] In Vitro Pharmacology of AVX-470, an Oral Anti-TNF Polyclonal Antibody for the Treatment of IBD
    Holdorf, Amy
    Lemos, Brenda
    Keane, David
    Quesenberry, Michael
    Clark, Shawn
    Bhol, Kailash
    Fox, Barbara
    Tracey, Daniel
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S95 - S95
  • [48] THE EFFECT OF CERTOLIZUMAB DRUG CONCENTRATION AND ANTI-DRUG ANTIBODIES ON TNF NEUTRALISATION
    Berkhout, L. C.
    Vogelzang, E. H.
    Hart, M. H.
    Derksen, N. I.
    Wieringa, R.
    van Leeuwen, W. A.
    Krieckaert, C. L.
    de Vries, A.
    Nurmohamed, M. T.
    Wolbink, G.
    Rispens, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 322 - 322
  • [49] The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation
    Berkhout, L. C.
    Vogelzang, E. H.
    Hart, M. H.
    Loeff, F. C.
    Dijk, L.
    Derksen, N. I. L.
    Wieringa, R.
    van Leeuwen, W. A.
    Krieckaert, C. L. M.
    de Vries, A.
    Nurmohamed, M. T.
    Wolbink, G. J.
    Rispens, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 306 - 313
  • [50] Utilizing Anti-TNF Levels and Drug Antibodies to De-escalate Therapy in Patients with IBD
    O'Brien, Corey
    Aguilar, Rodrigo
    Chang, Jennifer
    LeStrange, Aimee
    O'Hara, Melissa
    Mattar, Mark
    Charabaty, Aline
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S52 - S53
12345